To determine if the reduction in the growth of USP21-depleted tumor cells is functionally linked to the decrease in BRCA2 protein, we generated stable, BRCA2-transgenic HCC cell lines and followed clonogenic survival in the presence or absence of USP21 knockdown. The gene discussed is BRCA2; the disease is hepatocellular carcinoma.